ProfileGDS4132 / 212103_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 89% 90% 88% 86% 84% 86% 87% 86% 82% 85% 83% 87% 88% 81% 75% 80% 85% 88% 85% 85% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101377.1589
GSM201543Muscle PCOS pioglitazone 121398.33490
GSM201544Muscle PCOS pioglitazone 161414.04988
GSM201545Muscle PCOS pioglitazone 201373.70186
GSM201829Muscle PCOS pioglitazone 231332.16984
GSM201830Muscle PCOS pioglitazon 251345.92786
GSM201831Muscle PCOS pioglitazone 271363.57887
GSM201832Muscle PCOS pioglitazone 31332.60186
GSM201833Muscle PCOS pioglitazone 41289.47882
GSM201834Muscle PCOS pioglitazone 81343.3985
GSM201835Muscle PCOS after pioglitazone 102312.04983
GSM201836Muscle PCOS after pioglitazone 122383.94387
GSM201837Muscle PCOS after pioglitazone 162383.53588
GSM201838Muscle PCOS after pioglitazone 202294.80581
GSM201839Muscle PCOS after pioglitazone 232243.67575
GSM201840Muscle PCOS after pioglitazone 252294.93180
GSM201841Muscle PCOS after pioglitazone 272324.61585
GSM201842Muscle PCOS after pioglitazone 32387.76688
GSM201843Muscle PCOS after pioglitazone 42340.88185
GSM201844Muscle PCOS after pioglitazone 82343.96385